Dysregulation of miRNA expression in patients with chronic myelogenous leukemia at diagnosis: a systematic review

Mohammad Parsa-kondelaji,Maryam Musavi,Faezeh Barzegar,Neda Abbasian,Mehrdad Rostami,Mohammad R Seyedtaghia,Seyyed S Hashemi,Mahdiyeh Modi,Banafsheh Nikfar,Amir A Momtazi-Borojeni
DOI: https://doi.org/10.2217/bmm-2023-0575
2024-01-19
Biomarkers in Medicine
Abstract:Aim: The present systematic review aimed to explore miRNAs as a potential biomarker for early diagnosis of chronic myeloid leukemia (CML). Materials & methods: A systematic search was conducted in three electronic databases, including Web of Science, Scopus, and PubMed, to obtain relevant articles investigating the alteration of miRNA expression in patients with CML. Results: The authors found miRNAs whose expression changes are effective in the induction of CML disease. Among them, miR-21 and miR-155 were identified as the most common miRNAs with increased expression and miR-150 and miR-146 as the most common miRNAs with decreased expression. Conclusion: miRNAs can be used as an indicator for the early detection and treatment of CML phase.
medicine, research & experimental
What problem does this paper attempt to address?